In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 3, 1999, Pages 397-401

  Carrillo Munoz A J ^a   Quindos G ^b   Tur, C ^a   Ruesga, M T ^b   Miranda, Y ^b   Del Valle, O ^c   Cossum, P A ^d   Wallace, T L ^d  

^a Department of Microbiology Asesoria Cie y de Invest Apl ^*  (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d Antigenics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; ITRACONAZOLE; LIPOSOME; NYSTATIN;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA RUGOSA; CANDIDA TROPICALIS; CRYPTOCOCCUS; CRYPTOCOCCUS NEOFORMANS; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; RHODOTORULA; TRICHOSPORON; YEAST;

EID: 0032862342     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.3.397     Document Type: Article

References (12)

1. Wallace, T. L. & Lopez-Berestein, G. (1998) Nystatin and liposomal nystatin. In Antimicrobial Therapy and Vaccines (Yu, V. L., Merigan, T. C., Barriere, S. & White, N. J., Eds), pp. 1185-91. Williams & Wilkins, Baltimore, MD.
2. Gordon, L. E. (1995). Nystatin therapy in experimental coccichomycosis. American Review of Tuberculosis 72, 67-70.
3. Wallace, T. L., Paetznick, V., Cossum, P. A., López-Berestein, G., Rex, J. H. & Anaissie, E. (1997). Activity of liposomal nystatin against disseminated Aspergillus fumigatus in neutropenic mice. Antimicrobial Agents and Chemotherapy 41, 2238-43.
4. López-Berestein, G., Fainstein, V., Hopfer, R. L., Mehta, K., Sullivan, M. P., Keating, M. et al. (1985). Liposomal amphotericin-B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. Journal of Infectious Diseases 151, 704-10.
5. Gonzalez, C. E., Giri, N., Shetty, D., Klighys, K., Love, W., Sein, T. et al. (1996). Efficacy of a lipid formulation of nystatin against invasive pulmonary Aspergillosis. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA. Abstract B54, p. 31. American Society for Microbiology, Washington, DC.
6. Boutati, E., Maltezou, H. C., López-Berestein, G., Vartivarian, S. E. & Anaissie, E. J. (1995) Phase I study of maximum tolerated dose of intravenous liposomal nystalin for the treatment of refractory febrile neutropenia (RFN) in patients with haematological malignancies. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington, DC.
7. Roston, K., Baird, I., Graham, D. R. & Jauregui, L. (1998) Treatment of refractory candidemia in non-neutropenic patients with liposomal nystatin (NYOTRAN™). In Program and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Abstract, p. 31. American Society for Microbiology, Washington, DC.
8. Cossum, P. A., Wyse, J., Simmons, V., Wallace, T. L. & Rios, A (1996). Pharmacokinetics of NYOTRAN™ (liposomal nystatin) in human patients. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA. Abstract A88. p. 17. American Society for Microbiology, Washington, DC.
9. National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: M27-A. NCCLS, Villanova, PA.
10. Anaissie, E., Paetznick, V., Proffit, R., Adler-Moore, J. & Bodey, G. P. (1991). Comparison of the in-vitro antifungal activity of free and liposome-encapsulated amphotericin B. European Journal of Clinical Microbiology and Infectious Disease 10, 665-8.
11. Johnson, E. M., Ojwang, J. O., Szekely, A., Wallace, T. L. & Warnock, D. W. (1998) Comparison of in-vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations. Antimicrobial Agents and Chemotherapy 42, 1412-6.
12. Wallace, T. L. & Lopez-Berenstein, G. (1998). Nystatin and liposomal nystatin. In Antimicrobial Chemotherapy and Vaccines (Yu, V. L., Merigan, T. C., Barriere, S. & White, N. J., Eds), pp. 1185-91. Williams & Wilkins, Baltimore, MD.